Home > Healthcare > Medical Devices > Therapeutic Devices > Prostate Cancer Treatment Devices Market

Prostate Cancer Treatment Devices Market Trends

  • Report ID: GMI6089
  • Published Date: Jun 2023
  • Report Format: PDF

Prostate Cancer Treatment Devices Market Trends

Prostate cancer treatment devices have witnessed significant technological advancements in recent years. These advancements are intended to improve the accuracy and effectiveness of cancer diagnostics, staging, and treatment options.  Robotic-assisted surgery comprising the da Vinci Surgical System has revolutionized prostate cancer treatment though enabling minimally invasive procedures with smaller incisions, reduced blood loss, and faster recovery times. Advancements in technology such as real-time ultrasound imaging and thermal mapping have improved the accuracy and safety of cryotherapy procedures. This approach is particularly useful for localized prostate cancer and can be performed on an outpatient basis. Advances in genomic profiling and molecular diagnostics have led to the development of targeted therapies for advanced prostate cancer. These therapies aim to inhibit specific genetic mutations or pathways involved in cancer growth.
 

Moreover, brachytherapy involves the implantation of tiny radioactive seeds directly into the prostate gland. Technological advancements have allowed for better seed placement using real-time imaging guidance such as ultrasound or CT scans. This approach delivers high doses of radiation to the prostate while minimizing exposure to surrounding tissues. Overall, technological advancements hold promise in improving prostate cancer treatment efficiently.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of prostate cancer treatment devices materials was valued at around USD 3.4 billion in 2022 and will reach over USD 9.7 billion by 2032, attributable to the increasing prevalence of prostate cancer, technological advancements, and growing adoption of robotic-assisted surgeries.

The radiation treatment devices segment was valued at over USD 1.4 billion in 2022. Radiation therapy has a curative potential for localized prostate cancer and is particularly effective in early-stage cases where the cancer is confined to the prostate gland.

The U.S. market for prostate cancer treatment devices is anticipated to reach around USD 4.6 billion by 2032, owing to the increasing prevalence of prostate cancer, favourable reimbursement policies, numerous awareness & screening programs, and R&D activities.

Intuitive Surgical, Varian Medical Systems, Elekta, EDAP TMS, SonaCare Medical, and Medtronic among others.

Prostate Cancer Treatment Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 436
  • Countries covered: 30
  • Pages: 180
 Download Free Sample